◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

ENVERIC BIOSCIENCES, INC.

CIK: 890821 SIC: 2834
-
Revenue
$-9.73M
Net Income
-
Gross Margin
-
Op. Margin
$-14.34M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 39 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Research & Development $402.42K $1.26M $746.37K $1.10M $762.72K $515.50K
Operating Income $-1.87M $-2.52M $-2.19M $-3.17M $-2.08M $-1.90M
Other Income/Expense - $-132.00 $2.57K $26.38K $-840.00 $18.54K
Income Before Tax $-1.87M $-2.52M $-2.18M $-3.15M $-2.08M $-1.88M
Income Tax Expense - - - $7.20K - -
Net Income $-1.87M $-2.52M $-2.18M $-3.15M $-2.08M $-1.88M
Basic EPS -10.81 -0.97 -1.22 -18.09 -0.24 -0.25
Diluted EPS -10.81 -0.97 -1.22 -18.09 -0.24 -0.25
Basic Shares Outstanding 313K 2.6M 1.8M -6.3M 8.7M 7.6M
Diluted Shares Outstanding 313K 2.6M 1.8M -6.3M 8.7M 7.6M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $3.76M $2.85M $4.29M $2.24M $3.11M $3.50M
Other Current Assets $407.95K $457.56K $540.40K $493.56K $1.23M $2.02M
Total Current Assets $4.17M $3.31M $4.83M $2.73M $4.34M $5.52M
Property Plant & Equipment $196.52K $241.08K $267.28K $305.78K $367.69K $405.11K
Intangible Assets - - - $42.18K $84.37K $126.56K
Total Assets $4.36M $3.55M $5.10M $3.08M $4.79M $6.05M
Accounts Payable $683.71K $1.04M $669.19K $521.75K $576.32K $459.90K
Accrued Liabilities - - - $732.01K $253.15K $176.37K
Other Current Liabilities - - - - $4.94K $4.44K
Total Current Liabilities $905.88K $1.36M $1.18M $1.49M $839.17K $645.34K
Common Stock $5.18K $30.26K $24.72K $6.78K $89.95K $78.78K
Retained Earnings $-112.65M $-110.78M $-108.26M $-106.07M $-102.92M $-100.84M
Total Stockholders Equity $3.46M $2.18M $3.92M $1.59M $3.95M $5.41M
Total Liabilities & Equity $4.36M $3.55M $5.10M $3.08M $4.79M $6.05M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-1.87M $-4.70M $-2.18M $-3.15M $-2.08M $-1.88M
Depreciation & Amortization $40.37K $39.98K $81.02K $82.49K $255.00K $84.78K
Stock-based Compensation $587.09K $400.11K $193.85K $471.68K $1.09M $721.10K
Operating Cash Flow $-6.36M $-4.28M $-2.39M $-1.31M $-6.41M $-5.49M
Stock Issued - - - - $2.29M $2.29M
Financing Cash Flow $7.89M $4.90M $4.45M $463.45K $7.21M $6.69M
Net Change in Cash $1.52M $608.79K $2.05M $-870.66K $823.71K $1.21M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Research & Development $402.42K - $2.41M -
Operating Income $-1.87M - $-6.58M -
Interest Expense - - - -
Other Income/Expense - - $2.56K -
Income Before Tax $-1.87M - $-6.58M -
Income Tax Expense - - - -
Net Income $-1.87M $-1.88M $-6.58M -
Basic EPS -10.81 - -35.74 -
Diluted EPS -10.81 - -35.74 -
Basic Shares Outstanding $313.24K - $226.40K -
Diluted Shares Outstanding $313.24K - $226.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.76M $2.24M
Other Current Assets $407.95K $493.56K
Total Current Assets $4.17M $2.73M
Property Plant & Equipment $196.52K $305.78K
Intangible Assets - $42.18K
Total Assets $4.36M $3.08M
Accounts Payable $683.71K $521.75K
Other Current Liabilities - $232.89K
Total Current Liabilities $905.88K $1.49M
Common Stock $5.18K $565.00
Retained Earnings $-112.65M $-106.07M
Total Stockholders Equity $3.46M $1.59M
Total Liabilities & Equity $4.36M $3.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.87M $-1.88M $-6.58M -
Depreciation & Amortization $40.37K - $161.37K -
Stock-based Compensation - - $587.09K -
Operating Cash Flow - - $-6.36M -
Stock Issued - - - -
Financing Cash Flow - - $7.89M -
Net Change in Cash - - $1.52M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...